Medically reviewed by Allison Herries, RDN Neuropathy is a debilitating type of pain caused by injury or damage to nerves.

Pain Management Centers of America in Cordova abruptly closed its doors nearly a month ago, leaving nearly 2,000 patients ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...

MIAMI, FL / ACCESS Newswire / March 4, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on ...

“I was a very anxious teenager.” But when she went to college in California, the pain became overwhelming. “It was shooting ...

The following is a summary of “A Review of Nonsurgical Neurolytic Procedures for Neuropathic Pain,” published in the February ...

OKYO Pharma has filed a Fast Track designation application with the Food and Drug Administration (FDA) for urcosimod in the treatment of neuropathic ...

Adults with neuropathic pain use cannabis products more frequently than those without neuropathic pain. | Cannabis Sciences ...

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

The Company expects Phase 1 to conclude by Q4 2025, paving the way for a Phase 2a study in neuropathic pain patients to be initiated by the end of the year. Addressing a Large and Unmet Market for ...